Bayer Cropscience Q1 Review - Tepid Seed Sales Impacted Margins: Prabhudas Lilladher
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Prabhudas Lilladher Report
Bayer Cropscience Ltd. reported lackluster results, as all benefits of healthy topline growth were eaten away by 286 basis points decline in gross margins (to 44.5%) and higher than anticipated rise in other expenses (up 95 bps).
Bayer Cropscience's topline growth was driven by strong product liquidation in crop protection segment.
Corn seed sales volume were flat, as raw material supplies got impacted by delayed availability and acreage shift from maize in current Kharif season, given non remunerative price and deficit rainfall.
Post pick up in rainfall from July 10th onwards, maize acreages picked up and is likely to improve seed business in Q2.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.